Strategic News: Nuclear Medicine Equipment Industry to Hit $8.31B by 2030
The report “Nuclear Medicine Equipment Market by Product (Imaging: PET, SPECT, Gamma; GM Counter, Dose Calibrator), Software (Image Management, PACS, Treatment, Analytic, Workflow), Therapy (Onco, Cardio, Neuro, Ortho), End User & Region - Global Forecasts to 2030“, will grow to USD 8.31 billion by 2030 from USD 6.63 billion in 2025, at a CAGR of 4.62% during 2025-2030.
Browse 389 market data Tables and 50 Figures spread through 355 Pages and in-depth TOC on"Nuclear Medicine Equipment Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/nuclear-medicine-equipment-market-242495651.html
The key drivers of the market growth include the rising incidence of cancer and cardiovascular diseases, growing demand for early and precise diagnostic imaging, and increased adoption of hybrid imaging technologies like PET/CT and SPECT/CT. Further, the development of personalized medicine and theranostics, and government support for improving regulations & healthcare infrastructure are driving market growth. In addition, constant advancements in technology and the use of artificial intelligence in imaging devices are boosting diagnostic effectiveness and providing market players with new opportunities for growth.
The nuclear medicine software segment is the fastest-growing in the nuclear medicine equipment market.
The nuclear medicine software segment is the fastest-growing in the nuclear medicine equipment market. This is attributed to the increasing adoption of theranostic-based treatment approaches, which require specialized software for personalized dosimetry, real-time treatment response monitoring, and advanced image fusion, especially in oncology applications involving radioligand therapies like ^177Lu-PSMA and ^177Lu-DOTATATE. The need for specialized software tools is also being accelerated by regulatory changes like the Dosimetry Initiative of the SNMMI and the European Council Directive 2013/59/Euratom, which requires customized treatment planning. Additionally, vendors are implementing AI-powered features that facilitate kinetic modeling, quantitative evaluation, and lesion segmentation, which are quickly becoming crucial in busy cancer clinics and research facilities.
The oncology segment accounted for the largest share of the nuclear medicine equipment market.
This is due to the rising global prevalence of cancer, estimated to be more than 20 million new cases in 2022 and 35 million by 2050, which has significantly increased demand for early, precise, and functional imaging. Nuclear imaging techniques such as PET/CT and SPECT/CT are essential for cancer detection, staging, treatment planning, and response assessment. In addition, the increasing demand for radioligand therapies like ^177Lu-PSMA in prostate cancer and ^177Lu-DOTATATE in neuroendocrine tumors has increased the demand for advanced imaging systems and oncology-specific software. Innovation in the field of radiopharmaceuticals, regulatory backing for theranostics, and increasing reimbursement for cancer diagnostics have also helped dominate the market for this segment.
North America dominated the global nuclear medicine equipment market in 2024.
This is due to the high-level healthcare infrastructure in the region, extensive use of hybrid imaging modalities like PET/CT and SPECT/CT, and high emphasis on early disease detection and individualized medicine. The US alone performs close to 20 million nuclear medicine procedures every year due to the high incidence of cancer and cardiovascular disease. Moreover, the lucrative reimbursement schemes, large investments in nuclear medicine research, and prominent industry players such as GE Healthcare and Siemens Healthineers are supporting sustained market dominance. Government support for theranostic applications and ongoing clinical trials in radiopharmaceutical treatments further cemented the dominant position of North America.
The report profiles key players such as Hermes Medical Solutions (Sweden), DOSIsoft (France), Segami Corporation (US), GE HealthCare (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), and Canon Medical Systems Corporation (Japan).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Nuclear Medicine Equipment Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
